5 research outputs found

    Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.

    Get PDF
    To access publisher's full text version of this article click on the hyperlink belowAttention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, finding important new information about the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes and around brain-expressed regulatory marks. Analyses of three replication studies: a cohort of individuals diagnosed with ADHD, a self-reported ADHD sample and a meta-analysis of quantitative measures of ADHD symptoms in the population, support these findings while highlighting study-specific differences on genetic overlap with educational attainment. Strong concordance with GWAS of quantitative population measures of ADHD symptoms supports that clinical diagnosis of ADHD is an extreme expression of continuous heritable traits.Lundbeck Foundation Stanley Medical Research Institute European Research Council European Community (EC) EC Novo Nordisk Foundation Aarhus University NIH K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Norway NIMH Wellcome Trust personal Vici grant of the Netherlands Organisation for Scientific Research (NWO) European College of Neuropsychopharmacology (ECNP Network 'ADHD across the Lifespan') Stiftelsen K.G. Jebsen Copenhagen University Research Council of Norway Spanish 'Ministerio de Economia y Competitividad' Generalitat de Catalunya/AGAUR ECNP network 'ADHD across the lifespan' DFG KG Jebsen Stiftelsen Wellcome Trust Medical Research Council (MRC UK) Action Medical Research Australian National Health and Medical Research Council Australian Research Council NHMR

    Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder

    No full text
    corecore